Characterization of carbapenem-resistant Acinetobacter baumannii in Shanghai and Hong Kong [1]

Journal of Medical Microbiology

Volumn 55, Issue 6, 2006, Pages 799-802

  Ying, Chun Mei ^a   Ling, Thomas K W ^b   Lee, Ching Ching ^b   Ling, Julia M ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAMASE; CARBAPENEM; CEFEPIME; CEFOPERAZONE; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OXA 23; OXA 24; OXA 25; OXA 26; OXA 27; PALINDROMIC DNA; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; REPETITIVE DNA; SULBACTAM; SULPERAZON; SULTAMICILLIN; TICARCILLIN; TIMENTIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; AINETOBACTER BAUMANNII COMPLEX; ANTIBIOTIC RESISTANCE; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CHINA; GENE CLUSTER; HONG KONG; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; REPETITIVE EXTRAGENIC PALINDROMIC POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; SEQUENCE HOMOLOGY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BASE SEQUENCE; CARBAPENEMS; CHINA; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HONG KONG; HUMANS;

EID: 33744960474     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46117-0     Document Type: Letter

References (15)

1. Afzal-Shah, M. & Livermore, D. M. (1998). Worldwide emergence of carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother 41, 576-577.
2. Afzal-Shah, M., Woodford, N. & Livermore, D. M. (2001). Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 45, 583-588.
3. Bergogne-Berezin, E. & Towner, K. J. (1996). Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9, 148-165.
4. Clark, R. B. (1996). Imipenem resistance among Acinetobacter baumannii: association with reduced expression of a 33-36 KDa outer membrane protein. J Antimicrob Chemother 38, 245-251.
5. Clinical and Laboratory Standards Institute (2005). Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. Wayne, PA: Clinical and Laboratory Standards Institute.
6. Dimopoulou, I. D., Kartali, S. I., Kartalis, G. N., Manolas, K. I., Simopoulos, K. E., Vargemezis, B. A., Theodoropoulou-Rodiou, G., Bowler, I. C. & Crook, D. W. (2003). Relationship between nosocomial Acinetobacter species occurring in two geographical areas (Greece and the UK). J Hosp Infect 54, 207-211.
7. Donald, H. M., Scaife, W., Amyes, S. G. B. & Young, H. K. (2000). Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumanni 6B92. Antimicrob Agents Chemother 44, 196-199.
8. Héritier, C., Poirel, L., Lambert, T. & Nordmann, P. (2005). Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 49, 3198-3202.
9. Jiang, X., Yu, J. & Hong, X. (2002). A clinical strain of Acinetobacter baumannii which produces OXA-23 carbapenemase and PER-1 type ESBLs. Shanghai J Med Lab Sci 17, 263-267.
10. Martin-Lozano, D., Cisneros, J. M., Becerril, B., Cuberos, L., Prados, T., Ortiz-Leyba, C., Cañas, E. & Pachȯn, J. (2002). Comparison of a repetitive extragenic palindromic sequence-based PCR method and clinical and microbiological methods for determining strain sources in cases of nosocomial Acinetobacter baumannii bacteremia. J Clin Microbiol 40, 4571-4575.
11. Matthew, M., Harris, A. M., Marshall, M. & Ross, G. W. (1975). The use of analytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 88, 169-178.
12. National Commmittee for Clinical Laboratory Standards (2003). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 6th edn. Approved standard M7-A6. Wayne, PA: National Commmittee for Clinical Laboratory Standards.
13. Tenover, F. C., Arbeit R. & Archer, G. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33, 2233-2239.
14. Vahaboglu, H., Ozturk, R., Aygun, G. & Coskunkan, F. (1997). Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother 41, 2265-2269.
15. Vaneechoutte, M., Dijkshoorn, L., Tjernberg, I., Elaichouni, A., De Vos, P., Claeys, G. & Vershraegen, G. (1995). Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol 33, 11-15.